+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chromoendoscopy Agents Market - Global Forecast 2026-2032- Product Image
Chromoendoscopy Agents Market - Global Forecast 2026-2032- Product Image
Sale

Chromoendoscopy Agents Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010858
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chromoendoscopy Agents Market is projected to reach USD 179.97 Million in 2026. It is expected to continue growing at a CAGR of 5.59%, reaching USD 250.15 Million by 2032.

Chromoendoscopy agents are specialty dyes and contrast-enhancing solutions used during gastrointestinal endoscopy to improve mucosal visualization, support lesion characterization, and guide targeted biopsy. Key agents include indigo carmine, methylene blue, Lugol’s iodine, acetic acid, and crystal violet, each selected according to the clinical objective, anatomical site, safety profile, and endoscopist preference.

Demand is supported by the global burden of colorectal cancer, esophageal cancer, inflammatory bowel disease surveillance, and early gastrointestinal neoplasia detection. WHO and IARC global cancer statistics identify colorectal cancer among the most frequently diagnosed cancers worldwide, reinforcing the value of technologies that improve adenoma and dysplasia detection. In clinical practice, chromoendoscopy remains relevant because it can enhance contrast at the tissue surface, complement high-definition endoscopy, and support more precise surveillance in high-risk patients.

Transformative Shifts in the Chromoendoscopy Landscape

The chromoendoscopy agents landscape is shifting from procedure-dependent dye application toward integrated visualization strategies that combine high-definition scopes, image-enhanced endoscopy, standardized screening pathways, and advanced pathology workflows. Dye-based chromoendoscopy continues to be important in inflammatory bowel disease surveillance and targeted evaluation of subtle mucosal abnormalities, while virtual chromoendoscopy has expanded physician expectations for real-time contrast enhancement.

Market transformation is also being shaped by preventive screening policy. In the United States, the U.S. Preventive Services Task Force recommends colorectal cancer screening for adults aged 45 to 75, which has expanded the eligible screening population. In Europe and Asia-Pacific, national screening programs, aging populations, and broader endoscopy capacity are increasing the procedural base that can support selective use of chromoendoscopy agents in evidence-based diagnostic pathways.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is changing how chromoendoscopy agents are positioned in endoscopy suites. AI-assisted detection systems can flag suspicious polyps or mucosal patterns in real time, while chromoendoscopy dyes can improve surface contrast and help endoscopists characterize lesion margins. The combined workflow may support better documentation, targeted biopsy, and procedure standardization, particularly in high-volume screening centers.

The cumulative impact of AI is not limited to detection. AI-enabled quality metrics, automated reporting, image archiving, decision support, and training tools can make chromoendoscopy more reproducible across physician experience levels. However, adoption depends on validated algorithms, compatible imaging platforms, clinical guideline alignment, transparent performance reporting, and data governance that protects patient privacy while enabling continuous model improvement.

Key Regional Insights

Asia-Pacific is a high-priority region for chromoendoscopy agents due to large patient populations, rising colorectal cancer screening activity, and strong endoscopy infrastructure in Japan, South Korea, China, Australia, and Singapore. Japan has long been a leader in advanced endoscopic imaging and early gastrointestinal cancer detection, supporting sophisticated use of contrast techniques, while China and India are expanding diagnostic capacity through healthcare investment and wider access to specialist services.

North America benefits from mature gastroenterology networks, broad colorectal cancer screening recommendations, high adoption of high-definition endoscopy, and strong clinical emphasis on quality indicators such as adenoma detection. Latin America shows expanding opportunity as Brazil and Mexico strengthen private hospital systems and cancer screening awareness, although access varies significantly by urban and rural setting. Europe remains an important market because organized cancer screening, inflammatory bowel disease management, established endoscopy training, and European clinical guidance support high-quality mucosal assessment.

The Middle East is advancing through investment in tertiary hospitals, medical tourism, and specialist endoscopy centers, particularly in Gulf countries where healthcare modernization remains a policy priority. Africa remains an emerging region where adoption is concentrated in major urban hospitals and academic centers, with long-term demand tied to endoscopy training, procurement funding, workforce availability, and broader cancer diagnostic capacity.

Key Group Insights

ASEAN demand is supported by expanding hospital capacity, medical tourism in Thailand and Singapore, and growing awareness of gastrointestinal screening, although reimbursement, public-sector access, and specialist availability differ across member states. GCC countries are investing in premium hospital infrastructure, digital health, and specialist gastroenterology services, creating favorable conditions for advanced endoscopic visualization products and standardized clinical pathways.

The European Union offers a regulation-driven and guideline-oriented environment where organized screening, device and medicinal product compliance, and quality standards influence procurement. BRICS markets combine scale and heterogeneity: China and India provide large procedural potential, Brazil and South Africa act as regional healthcare hubs, and Russia maintains demand through established hospital networks despite procurement complexity and supply-chain sensitivity.

G7 countries remain important for clinical validation, premium product adoption, and evidence generation because of advanced endoscopy infrastructure, strong academic medical centers, and established reimbursement systems. NATO countries overlap substantially with North America and Europe, where security of medical supply chains, regulatory compliance, hospital resilience, and continuity of essential diagnostic supplies increasingly shape procurement planning for chromoendoscopy agents.

Key Country Insights

The United States is a leading market due to large screening volumes, strong gastroenterology specialization, and USPSTF recommendations that include adults aged 45 to 75 for colorectal cancer screening. Canada benefits from provincial screening programs and high clinical standards, while Mexico shows opportunity in private hospitals and urban specialty centers. Brazil is Latin America’s largest healthcare market and supports demand through major metropolitan hospital systems, expanding oncology services, and rising awareness of gastrointestinal disease detection.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain significant demand through colorectal cancer screening, inflammatory bowel disease care, and advanced endoscopy practices. Germany and France are particularly influential in technology adoption and specialist clinical infrastructure, while the United Kingdom emphasizes evidence-based pathway implementation through national guidance and organized service delivery. Russia remains a sizable market, though procurement, reimbursement, and supply continuity can be challenging.

China and India represent large long-term opportunities because of population scale, rising cancer awareness, expanding endoscopy capacity, and healthcare investment. Japan is a mature innovation-led market with deep expertise in early gastrointestinal cancer detection and advanced mucosal imaging. Australia has strong screening infrastructure and specialist practice standards, while South Korea combines high endoscopy utilization with advanced hospital technology adoption and strong preventive health engagement.

Actionable Recommendations for Industry Leaders

Industry leaders should position chromoendoscopy agents as part of a broader precision endoscopy ecosystem rather than as standalone consumables. Commercial strategies should emphasize clinically relevant use cases such as inflammatory bowel disease surveillance, Barrett’s esophagus assessment, early gastric cancer evaluation, squamous dysplasia detection, and targeted colorectal lesion characterization.

Manufacturers should invest in physician education, standardized dye-preparation protocols, safety documentation, shelf-life controls, and compatibility data with high-definition and image-enhanced endoscopy platforms. Partnerships with AI developers, endoscopy equipment providers, hospital networks, and academic centers can strengthen evidence generation and support differentiated value propositions. Market access teams should align with screening guidelines, procurement priorities, formulary requirements, and regional reimbursement realities.

Research Methodology

This executive summary is based on secondary research from verified public health agencies, clinical guideline bodies, peer-reviewed gastroenterology literature, regulatory sources, and healthcare infrastructure indicators. Key reference areas include cancer epidemiology, colorectal screening guidance, inflammatory bowel disease surveillance practices, endoscopy technology adoption, artificial intelligence in endoscopy, and regional healthcare investment trends.

The methodology combines qualitative market assessment with evidence triangulation across clinical practice, regulatory context, demand drivers, and regional healthcare access indicators. Insights were evaluated for consistency across reputable sources, relevance to chromoendoscopy agents, and applicability to regional, group-level, and country-level market dynamics. No unsupported market-size estimates, market-share claims, or forecasting assumptions are used.

Conclusion

The chromoendoscopy agents market is supported by durable clinical needs in early cancer detection, dysplasia surveillance, and precision endoscopic assessment. While virtual chromoendoscopy and AI are reshaping visualization workflows, dye-based agents remain clinically relevant where enhanced mucosal contrast, lesion margin definition, and targeted evaluation are required.

Future performance will depend on procedural volume, guideline alignment, physician training, supply reliability, regulatory compliance, and evidence demonstrating improved diagnostic confidence. Organizations that integrate chromoendoscopy agents into AI-enabled, high-definition, quality-focused endoscopy pathways will be best positioned to address evolving clinical demand without compromising safety, standardization, or diagnostic precision.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Chromoendoscopy Agents Market, by Staining Agent
7.1. Introduction
7.2. Absorptive Agents
7.2.1. Methylene Blue
7.2.2. Lugol's Iodine
7.2.3. Crystal Violet
7.3. Contrast Agents
7.4. Reactive Agents
7.4.1. Congo Red
7.4.2. Phenol Red
8. Chromoendoscopy Agents Market, by Indication
8.1. Introduction
8.2. Colorectal Cancer Screening
8.3. Inflammatory Bowel Disease
8.3.1. Ulcerative Colitis
8.3.2. Crohn Disease
8.4. Barrett Esophagus
8.5. Gastric Cancer Screening
8.6. Polyposis Syndromes
9. Chromoendoscopy Agents Market, by Formulation Type
9.1. Introduction
9.2. Aqueous Solutions
9.3. Powders For Reconstitution
10. Chromoendoscopy Agents Market, by Delivery Method
10.1. Introduction
10.2. Topical Endoluminal
10.2.1. Spray Catheter Delivery
10.2.2. Through-The-Scope Sprays
10.3. Rectal Administration
10.4. Oral & Enteral Administration
11. Chromoendoscopy Agents Market, by Application Area
11.1. Introduction
11.2. Colon And Rectum
11.3. Esophagus
11.4. Stomach
11.5. Biliary Tract
11.6. Small Intestine
12. Chromoendoscopy Agents Market, by End User
12.1. Introduction
12.2. Hospitals
12.3. Ambulatory Surgical Centers
12.4. Diagnostic Imaging & Endoscopy Centers
12.5. Specialty Clinics
13. Chromoendoscopy Agents Market, by Patient Demographics
13.1. Introduction
13.2. Adult Patients
13.3. Pediatric Patients
13.4. Geriatric Patients
14. Chromoendoscopy Agents Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Chromoendoscopy Agents Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Chromoendoscopy Agents Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. Japan
16.5. India
16.6. United Kingdom
16.7. France
16.8. Canada
16.9. Italy
16.10. Australia
16.11. South Korea
16.12. Brazil
16.13. Mexico
16.14. Russia
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Alcon Laboratories
18.2. American Regent, Inc.
18.3. Bio-Rad Laboratories, Inc.
18.4. Boston Scientific Corporation
18.5. Carmonja GmbH
18.6. Cerba Research SA
18.7. Cook Medical LLC
18.8. Cosmo Pharmaceuticals NV.
18.9. Enzo Life Sciences, Inc.
18.10. Fujifilm Holdings Corporation
18.11. Hikma Pharmaceuticals PLC
18.12. HISTALIM
18.13. HOYA Corporation
18.14. KARL STORZ SE & Co. KG
18.15. LobaChemie Pvt. Ltd.
18.16. Long Grove Pharmaceuticals, LLC by Capstone Development Services Company, LLC
18.17. Macsen Labs
18.18. Merck KGaA
18.19. Micro-Tech Endoscopy
18.20. Provepharm Life solutions SA
18.21. Renylab Quimica E Farmaceutica Ltda.
18.22. Sisco Research Laboratories Pvt. Ltd.
18.23. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL CHROMOENDOSCOPY AGENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CHROMOENDOSCOPY AGENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CHROMOENDOSCOPY AGENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CHROMOENDOSCOPY AGENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL CHROMOENDOSCOPY AGENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ABSORPTIVE AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ABSORPTIVE AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ABSORPTIVE AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL METHYLENE BLUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL METHYLENE BLUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL METHYLENE BLUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LUGOL'S IODINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LUGOL'S IODINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LUGOL'S IODINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CRYSTAL VIOLET MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CRYSTAL VIOLET MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CRYSTAL VIOLET MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTRAST AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL REACTIVE AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REACTIVE AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REACTIVE AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CONGO RED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CONGO RED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CONGO RED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PHENOL RED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PHENOL RED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PHENOL RED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INFLAMMATORY BOWEL DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CROHN DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CROHN DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CROHN DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL BARRETT ESOPHAGUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL BARRETT ESOPHAGUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BARRETT ESOPHAGUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL GASTRIC CANCER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL GASTRIC CANCER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL GASTRIC CANCER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POLYPOSIS SYNDROMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POLYPOSIS SYNDROMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POLYPOSIS SYNDROMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL POWDERS FOR RECONSTITUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL POWDERS FOR RECONSTITUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL POWDERS FOR RECONSTITUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TOPICAL ENDOLUMINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TOPICAL ENDOLUMINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TOPICAL ENDOLUMINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SPRAY CATHETER DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SPRAY CATHETER DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SPRAY CATHETER DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL THROUGH-THE-SCOPE SPRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL THROUGH-THE-SCOPE SPRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL THROUGH-THE-SCOPE SPRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL RECTAL ADMINISTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RECTAL ADMINISTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RECTAL ADMINISTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ORAL & ENTERAL ADMINISTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ORAL & ENTERAL ADMINISTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ORAL & ENTERAL ADMINISTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL COLON AND RECTUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL COLON AND RECTUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL COLON AND RECTUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ESOPHAGUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ESOPHAGUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ESOPHAGUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL STOMACH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL STOMACH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL STOMACH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BILIARY TRACT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BILIARY TRACT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BILIARY TRACT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SMALL INTESTINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SMALL INTESTINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SMALL INTESTINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DIAGNOSTIC IMAGING & ENDOSCOPY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DIAGNOSTIC IMAGING & ENDOSCOPY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC IMAGING & ENDOSCOPY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ADULT PATIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ADULT PATIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ADULT PATIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 127. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 128. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 129. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 131. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 132. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 133. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 134. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 135. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 161. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 163. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 164. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 165. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 166. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 167. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 168. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 169. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 170. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 171. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 188. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 189. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 190. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 191. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 192. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 193. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 194. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 195. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 196. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 198. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 200. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 201. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 202. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 203. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 204. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 205. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 206. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 207. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 208. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 222. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 224. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 225. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 226. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 227. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 228. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 229. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 230. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 231. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 232. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 234. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 235. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 236. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 237. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 238. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 239. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 240. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 241. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 242. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 243. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 244. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 246. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 248. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 249. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 250. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 251. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 252. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 253. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 254. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 255. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 256. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 258. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 271. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 273. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 274. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 275. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 276. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 277. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 278. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 279. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 280. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 281. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. CHINA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 283. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 285. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 286. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 287. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 288. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 289. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 290. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 291. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 292. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 293. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. GERMANY CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 295. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 297. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 298. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 299. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 300. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 301. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 302. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 303. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 304. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 305. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. JAPAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 307. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 309. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 310. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 311. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 312. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 313. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 314. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 315. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 316. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 317. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. INDIA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 328. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 331. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 332. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 333. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 334. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 335. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 336. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2017-2032 (USD MILLION)
TABLE 337. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 338. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 339. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY TOPICAL ENDOLUMINAL, 2017-2032 (USD MILLION)
TABLE 340. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 341. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 342. FRANCE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2017-2032 (USD MILLION)
TABLE 343. CANADA CHROMOENDOSCOPY AGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 344. CANADA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY STAINING AGENT, 2017-2032 (USD MILLION)
TABLE 345. CANADA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ABSORPTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 346. CANADA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REACTIVE AGENTS, 2017-2032 (USD MILLION)
TABLE 347. CAN

Companies Mentioned

  • Alcon Laboratories
  • American Regent, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Carmonja GmbH
  • Cerba Research SA
  • Cook Medical LLC
  • Cosmo Pharmaceuticals NV.
  • Enzo Life Sciences, Inc.
  • Fujifilm Holdings Corporation
  • Hikma Pharmaceuticals PLC
  • HISTALIM
  • HOYA Corporation
  • KARL STORZ SE & Co. KG
  • LobaChemie Pvt. Ltd.
  • Long Grove Pharmaceuticals, LLC by Capstone Development Services Company, LLC
  • Macsen Labs
  • Merck KGaA
  • Micro-Tech Endoscopy
  • Provepharm Life solutions SA
  • Renylab Quimica E Farmaceutica Ltda.
  • Sisco Research Laboratories Pvt. Ltd.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 179.97 Million
Forecasted Market Value ( USD ) by 2032 $ 250.15 Million
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Chromoendoscopy Agents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Chromoendoscopy Agents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Endoscopic Submucosal Dissection - Global Strategic Business Report - Product Image

Endoscopic Submucosal Dissection - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Endoscopy Visualization Systems - Global Strategic Business Report - Product Image

Endoscopy Visualization Systems - Global Strategic Business Report

  • Report
  • 361 Pages
  • Global
From
Flexible Endoscopes Market - Global Forecast 2026-2032 - Product Image

Flexible Endoscopes Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Endoscopic Submucosal Dissection Market - Global Forecast 2026-2032 - Product Image

Endoscopic Submucosal Dissection Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.